Summary:
Our purpose was to evaluate frequency and severity of bone mineral decrements and frequency of osteonecrosis in survivors of pediatric allogeneic bone marrow transplantation (alloBMT). We retrospectively reviewed demographic information, treatment, magnetic resonance (MR) imaging studies (hips and knees), and bone mineral density (BMD) studies of 48 patients as measured by quantitative computed tomography (QCT). In all, 24 patients were male; 37 were Caucasian. Median age at alloBMT was 10.3 years (1.6–20.4 years). Of the 48 patients, 43 underwent QCT. Median time between alloBMT and imaging was 5.1 years (1.0–10.2 years). Median BMD Z-score was −0.89 (−4.06 to 3.05). BMD Z-score tended to be associated with female sex (P=0.0559) but not with age at BMT, race, primary diagnosis, time from alloBMT, T-cell depletion of graft, total-body irradiation, or acute/chronic graft-versus-host disease (GVHD). MR showed osteonecrosis in 19 of 43 (44%). We found no associations between osteonecrosis and sex, race, diagnosis, age at BMT, history of GVHD, time from BMT, or T-cell depletion. Seven patients (15%) had MR changes of osteonecrosis and BMD Z-scores of less than –1 s.d. We conclude that pediatric alloBMT survivors have decreased BMD and are at risk of osteonecrosis. They should be monitored to assure early intervention that may ameliorate adverse outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kolb H-J, Poetscher C . Late effects after allogeneic bone marrow transplantation. Curr Opin Hematol 1997; 4: 401–407.
Dicke KA . Late effects after allogeneic bone marrow transplantation. Bone Marrow Transplant 1994; 14: S11–S13.
Schimmer AD, Minden MD, Keating A . Osteoporosis after blood and marrow transplantation: clinical aspects. Biol Blood Marrow Transplant 2000; 6: 175–181.
Ebeling PR, Thomas DM, Erbas B et al. Mechanisms of bone loss following allogeneic and autologous hematopoietic stem cell transplantation. J Bone Miner Res 1999; 14: 342–350.
Cann CE . Quantitative CT for determination of bone mineral density: a review. Radiology 1988; 166: 509–522.
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295–304.
QCT PRO Technical Manual. Mindways Software, South San Francisco, CA 94080. USA.
Cann CE, Genant HK . Precise measurement of vertebral mineral content using computed tomography. J Comput Assist Tomogr 1980; 4: 493–500.
Cann CE, Genant HK, Kolb FO et al. Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985; 6: 1–7.
Lenchik L, Sartoris DJ . Current concepts in osteoporosis. Am J Radiol 1997; 168: 905–911.
Kanis JA, Melton LJ, Christiansen C et al. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9: 1137–1141.
Osteoporosis Foundation Physicians's Guide to Prevention and Treatment of Osteoporosis. Excerpta Medica Inc.: Belle Mead, NJ, USA 1998.
Mont MA, Hungerford DS . Current concepts review: non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg 1995; 77-A: 459–470.
Mont MA, Baumgarten KM, Rigai A et al. Atraumatic osteonecrosis of the knee. J Bone Joint Surg 2000; 82-A: 1279–1290.
Takatori Y, Kokubo T, Ninomiya S et al. Avascular necrosis of the femoral head. J Bone Joint Surg (Br) 1993; 75-B: 217–221.
Koo K-H, Ahn I-O, Kim R et al. Bone marrow edema and associated pain in early stage osteonecrosis of the femoral head: prospective study with serial MR images. Radiology 1999; 213: 715–722.
Beltran J, Herman LJ, Burk JM et al. Femoral head avascular necrosis: MR imaging with clinical-pathologic and radionuclide correlation. Radiology 1988; 166: 215–220.
Gillespy III T, Genant HK, Helms CA . Magnetic resonance imaging of osteonecrosis. Radiol Clin N Am 1986; 24: 193–208.
Gabriel H, Fitzgerald SW, Myers MT et al. MR imaging of hip disorders. Radio Graphics 1994; 14: 763–781.
Kaste SC, Poquette CA, Tan M et al. Thallium bone imaging as an indicator of response and outcome in nonmetastatic primary extremity osteosarcoma (OS). Pediatr Radiol 2001; 31: 251–256.
Kaste SC, Chesney RW, Hudson MM et al. Bone mineral status during and after therapy of childhood cancer: an increasing population with multiple risk factors for impaired bone health. J Bone Miner Res 1999; 14: 2010–2014.
Weilbaecher KN . Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000; 6: 165–174.
Enright H, Haake R, Weisdorf D . Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990; 89: 733–738.
Stern J, Chestnut III CH, Bruemer B et al. Bone density loss during treatment of chronic GVHD. Bone Marrow Transplant 1996; 17: 395–400.
Bhatia S, Ramsay NKC, Weisdorf D et al. Bone mineral density in patients undergoing bone marrow transplantation of myeloid malignancies. Bone Marrow Transplant 1998; 22: 87–90.
Chesney RW, Mazess RB, Hamstra AJ et al. Reduction of serum 1,25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet 1978; 2: 1123–1125.
Reid IR . Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989; 30: 83–103.
Godschalk M, Levy JR, Downs Jr RW . Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells. J Bone Miner Res 1992; 7: 21–27.
Epstein S, Shane E, Bilezikian JP . Organ transplantation and osteoporosis. Curr Opin Rheumatol 1995; 7: 225–261.
Shane E, Rivas MDC, Silverberrg SJ et al. Osteoporosis after cardiac transplantation. Am J Med 1993; 94: 257–264.
Lukert BP, Raisz LG . Glucocorticoid-induced osteoporosis. Rheumatol Dis Clin N Am 1994; 20: 629–650.
Lukert BP, Raisz LG . Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352–364.
Joseph JC . Corticosteroid-induced osteoporosis. Am J Hosp Pharmacol 1994; 51: 188–197.
Southard RN, Morris JD, Mahan JD et al. Bone mass in healthy children: measurement with quantitative DXA. Radiology 1991; 179: 735–738.
Bockman RS, Weinerman SA . Steroid-induced osteoporosis. Orthop Clin N Am 1990; 21: 97–107.
Stanisavljevic S, Babcock AL . Fractures in children treated with methotrexate for leukemia. Clin Orthop Relat Res 1977; 125: 139–144.
Ragab AH, Frech RS, Vietti TJ . Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer 1970; 25: 580–585.
Schwartz AM, Leonidas JC . Methotrexate osteopathy. Skeletal Radiol 1984; 11: 13–16.
Nesbit M, Krivit W, Heyn R et al. Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems. Cancer 1976; 37: 1048–1054.
Gilsanz V, Carlson ME, Roe TF et al. Osteoporosis after cranial irradiation for acute lymphoblastic leukemia. J Pediatr 1990; 117: 238–244.
Henderson RC, Madsen CD, Davis C et al. Bone density in survivors of childhood malignancies. J Pediatr Hematol Oncol 1996; 18: 367–371.
Hoorweg-Nijman JJG, van Dijk HJ, Roos PR et al. Bone mineralization after (treatment for) acute lymphoblastic leukemia. SIOP XXVIII Meeting 1996, (abstr). Vienna, Austria.
Kashyap A, Kandeel F, Yamauchi D et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study. Biol Blood Marrow Transplant 2000; 6: 344–351.
Sanders JE, Hawley J, Levy W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052.
Sanders JE . Bone marrow transplantation for pediatric malignancies. Pediatr Clin N Am 1997; 44: 1005–1020.
Atkinson K, Cohen M, Biggs J . Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant 1987; 2: 421–426.
Apperley JF, Reddy N . Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev 1995; 9: 93–116.
Atkinson K, Cohen M, Biggs J . Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant 1987; 2: 421–426.
Pieters R, van Brenk, Veerman AJP et al. Bone marrow magnetic resonance studies in childhood leukemia. Cancer 1987; 60: 2994–3000.
Mont MA, Carbone JJ, Fairbank AC . Core decompression versus nonoperative management for osteonecrosis of the hip. Clin Ortho Relat Res 1996; 324: 169–178.
Hongeng S, Krance RA, Bowman LC et al. Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children and adolescents. Lancet 1997; 350: 767–771.
Acknowledgements
This work is supported in part by grant P30 CA-21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaste, S., Shidler, T., Tong, X. et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 33, 435–441 (2004). https://doi.org/10.1038/sj.bmt.1704360
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704360
Keywords
This article is cited by
-
Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity
Journal of Clinical Immunology (2023)
-
Osteonekrosen – gravierende Therapiefolge bei akuter lymphoblastischer Leukämie
Die Orthopädie (2022)
-
Pre- and post-magnetic resonance imaging of hips and knees for detecting osteonecrosis in children and adolescents undergoing hematopoietic cell transplantation
Bone Marrow Transplantation (2020)
-
A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation
Cancer and Metastasis Reviews (2020)
-
Long-term Effects of Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Lymphoblastic Leukemia
Current Oncology Reports (2018)